Rivaroxaban Reduces Heart Attack, Stroke and Death in Patients With ACS

The ATLAS ACS 2-TIMI 51 study found that, when added to standard medical treatment, rivaroxaban reduced the risk of heart attack, stroke or cardiovascular death in patients recently diagnosed with ACS.
Source: BWH News - Category: Hospital Management Source Type: news